Filter
1917
Filtered Results: 1917
Text search:
and
A.
Rouse
Featured
Recommendations
272
New Publications
413
Language
Document type
No document type
587
Guidelines
443
Studies & Reports
418
Manuals
224
Strategic & Response Plan
115
Training Material
69
Fact sheets
37
Infographics
8
Situation Updates
7
Resource Platforms
5
Brochures
3
Videos
1
Countries / Regions
Global
142
India
68
Latin America and the Carribbean
36
Western and Central Europe
33
Kenya
32
Liberia
32
South–East Asia Region
28
Sierra Leone
27
Ukraine
26
Nigeria
26
Africa
25
Eastern Europe and Central Asia
21
Rwanda
20
Ethiopia
20
South Africa
19
Uganda
17
Ghana
16
Myanmar / Burma
16
Philippines
15
Tanzania
14
Bangladesh
14
Syria
13
Nepal
12
Middle East and North Africa
12
Asia
11
West and Central Africa
11
South Sudan
11
Guinea
10
Congo, Democratic Republic of
10
East and Southern Africa
10
Western Pacific Region
9
Malawi
7
Haiti
7
Yemen
7
Afghanistan
6
Russia
6
Pakistan
6
Jordan
5
Sudan
5
Zambia
5
Somalia
5
Tajikistan
4
Thailand
4
Senegal
4
Cambodia
4
Lebanon
4
Eastern Europe
4
Iraq
4
North Macedonia
3
Timor Leste/ East Timor
3
Cameroon
3
Iran
3
Burkina Faso
3
Mozambique
3
Venezuela
3
Côte d’Ivoire / Ivory Coast
3
Namibia
3
Egypt
3
Colombia
2
Lesotho
2
Turkey
2
Kazakhstan
2
Laos
2
Kyrgyzstan
2
Peru
2
Zimbabwe
2
USA
2
Saudi Arabia
2
North America
2
Vietnam
2
Djibouti
2
Georgia
2
Mali
2
Botswana
2
Indonesia
2
Ecuador
2
Eswatini/ Swaziland
2
North Korea
1
Serbia
1
Benin
1
China
1
Chile
1
Albania
1
Singapore
1
Estonia
1
Uzbekistan
1
Morocco
1
Mongolia
1
Qatar
1
Bulgaria
1
Armenia
1
Germany
1
Ireland
1
Paraguay
1
Denmark
1
Mauritius
1
Tunisia
1
Azerbaijan
1
Belarus
1
French Guyana
1
Bolivia
1
Brazil
1
Sri Lanka
1
Greece
1
Palestine
1
Angola
1
Chad
1
Libya
1
Bhutan
1
Authors & Publishers
Publication Years
Category
Countries
421
Clinical Guidelines
261
Public Health
185
Key Resources
167
Women & Child Health
150
Capacity Building
62
Pharmacy & Technologies
57
Toolboxes
COVID-19
212
HIV
131
Mental Health
130
Caregiver
118
Planetary Health
118
TB
108
Rapid Response
88
AMR
86
Ebola
79
NTDs
68
Pharmacy
55
Global Health Education
53
NCDs
48
Disability
40
Conflict
40
Natural Hazards
31
Refugee
23
Health Financing Toolbox
15
Cholera
11
Specific Hazards
9
Polio
7
Zika
5
Social Ethics
2
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.
2016-2018 Early implementation,
This report presents 2015 data on the consumption of systemic antibiotics from 65 countries and areas, contributing to our understanding of how antibiotics are used in these countries. In addition, the report documents early efforts of the World Health Organization (...
This document aims to provide concrete, pragmatic guidance for how TB modelling and related technical assistance is undertaken to support country decision-making. The target audience for this document are the participants and stakeholders in country-level TB modelling efforts, including the individu...
Version 1.1. The WHO protocol has been adapted to resource-limited settings and builds on existing methodologies from the European Centre for Disease Prevention and Control (ECDC), the Global PPS project from University of Antwerp, the US Centers for Disease Control and Prevention (CDC), and the Med...
This new guideline on non-clinical interventions to reduce unnecessary caesarean sections incorporates the views, fears and beliefs of both women and health professionals about caesarean sections. It also considers the complex dynamics and limitations of health systems and organizations and relation...
WHO Recommendations 2018 Update
The primary audience for these recommendations includes health professionals who are responsible for developing national and local health care guidelines and protocols (particularly those related to PPH prevention and treatment) and those involved in the provision of...
Module 1
Clinical
July 2017
Module 1: Clinical. This module is for clinicians, including physicians, nurses and clinical officers. It gives an overview of how to provide PrEP safely and effectively, including: screening for substantial risk of HIV; performing appropriate testing before initi...
Module 9
Strategic planning
July 2017
Module 9: Strategic planning. As WHO recommends offering PrEP to people at substantial HIV risk, this module offers public health guidance for policy-makers on how to prioritize services, in order to reach those who could benefit most from PrEP, and in wh...
The WHO COVID-19 Clinical management: living guidance contains the Organization’s most up-to-date recommendations for the clinical management of people with COVID-19. Providing guidance that is comprehensive and holistic for the optimal care of COVID-19 patients throughout their entire illness is ...
6 July 2021. Three new nucleic acid amplification test (NAAT) classes are endorsed by WHO and included.
The latest operational handbook includes the new classes recommended by WHO. It aims at facilitating the implementation of the WHO recommendations by the Member States, technical partners, and ot...
The two-year impact report for the Access to COVID-19 Tools (ACT) Accelerator details impact, case studies and timelines of key milestones for the Diagnostics, Therapeutics and Vaccines pillars, as well as the Health Systems and Response Connector.
Guidelines on the management of chronic pain in children, developing and implementing national and local policies for pain management and protocols in children, implementing national and local regulations for pain management in children, pain management and protocols
The recommendations cover the level of blood pressure to start medication, what type of medicine or combination of medicines to use, the target blood pressure level, and how often to have follow-up checks on blood pressure. In addition, the guideline provides the basis for how physicians and other h...
WHO’s antiretroviral treatment (ART) clinic-based acquired drug resistance survey method yields robust estimates of HIV viral suppression and acquired HIV drug resistance in adults, children and adolescents taking both dolutegravir and non-dolutegravir based regimens.
Results are used to inform A...
In 2015, 5.9 million children under age five died (1). The major causes of child deaths globally are pneumonia, prematurity, intrapartum-related complications, neonatal sepsis, congenital anomalies, diarrhoea, injuries and malaria (2). Most of these diseases and conditions are at least partially cau...
Many of the countries in the European Region receiving refugees from Ukraine are already offering vaccination services to children and adults. This is important to mitigate the risk of COVID-19 transmission among people travelling or living in close quarters, to protect the refugees from diseases th...
The mhGAP community toolkit: field test version is an integral part of WHO's Mental Health Gap Action Programme (mhGAP), and aims at scaling up services for people with mental health conditions to achieve universal health coverage.
The toolkit provides guidance for programme managers on how to i...
Government of Nepal has an obligation to ensure availability of affordable and high quality basic health care services to its population
WHO’s sentinel surveys of acquired HIV resistance to dolutegravir among people receiving dolutegravir-containing antiretroviral therapy is intended for easy and frequent implementation. Results from sentinel surveys provide insight into the prevalence and year-over-year trends of dolutegravir resi...
This document summarizes the results of the WHO-commissioned full value proposition for new tuberculosis (TB) vaccines. The assessment was commissioned to provide early evidence for national and global decision-makers involved in TB vaccine development and implementation, who include stakeholders in...
